Nikhil Singh
@nikhil-singh.bsky.social
📤 1537
📥 366
📝 0
ID/AMS Pharmacist 💊 |
@NCICancer.bsky.social
@Petermaccc.bsky.social
reposted by
Nikhil Singh
Violet Zhu
5 months ago
Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes
#IDPharmacistsDay
#SIDPAdvocacy
@adphaau.bsky.social
@sidpharm.bsky.social
@ncicancer.bsky.social
2
24
7
reposted by
Nikhil Singh
Jonathan Ryder, MD
6 months ago
From
@cmijournal.bsky.social
: Which trial do we need? Ampicillin versus ampicillin plus ceftriaxone for E. faecalis endocarditis Would love to see this trial happen!
#IDSky
www.clinicalmicrobiologyandinfection.com/article/S119...
loading . . .
Which trial do we need? Ampicillin versus ampicillin plus ceftriaxone for E. faecalis endocarditis: is it time to start re-considering monotherapy?
Reviewing the evidence behind some established practices in infectious diseases is both a professional responsibility and an ethical duty of the scientific community. Combination therapy for Enterococ...
https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(25)00155-7/fulltext
5
22
8
reposted by
Nikhil Singh
Sean Ong
11 months ago
Feels right that my 1st post here should be to share this incredible RCT, led by my PhD supervisor Nick Daneman:
www.nejm.org/doi/full/10....
Main takeaway: 7-days of abx should be the standard of care for patients with uncomplicated non-S. aureus BSI. A deep dive 🧵:
#IDsky
loading . . .
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...
https://www.nejm.org/doi/full/10.1056/NEJMoa2404991
7
118
42
you reached the end!!
feeds!
log in
